Moderna Says Its Coronavirus Vaccine Is 94.5% Effective

CDC Image.

CAMBRIDGE, MA – American biotech company Moderna says its Coronavirus vaccine is nearly 95-percent effective.

The company released its early clinical trial data on Monday morning.








Moderna plans to seek FDA authorization for the immunization after more safety data is gathered later this month.

Of the 15,000 participants who received the vaccine, only five contracted COVID-19 and none became seriously ill.









It’s the second vaccine in the united states to have a stunningly high success rate.

Last week, Pfizer announced that early data shows its vaccine is more than 90-percent effective against the virus.















The nation’s top infectious disease expert Doctor Anthony Fauci says COVID-19 vaccinations could start as soon as mid-December.

It’s expected that high-risk groups like health care workers, the elderly, and people with underlying medical conditions would get the vaccine first.

It could be available to everyone else by spring.

 

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.